The American College of Chest Physicians and the European Respiratory Society issued bronchiectasis guidelines recently. Here ...

Bronchiectasis, a chronic inflammatory lung disease characterized by clinical cough, sputum production and recurrent respiratory infections, is entering the spotlight, with clinic ...

Bronchiectasis appears to share genetic signals with chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis, and a cross-ancestry genetic analysis of more than 1.8 million people ...

Add Yahoo as a preferred source to see more of our stories on Google. Sep. 24—(StatePoint) Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 ...

Updated clinical guidelines for adult bronchiectasis suggest long-term macrolide or brensocatib therapy to reduce frequent ...

Brensocatib hydrate (Brinsupri; Insmed Inc) launched commercially in Japan on October 19 for adults and children 12 years and ...

If you have bronchiectasis, the essential goal of treatment is to keep your airway clear. Bronchiectasis is a chronic lung condition in which the airways become widened and damaged, making it harder ...

If you have non-cystic fibrosis bronchiectasis, you’re likely an expert on the “lung side” of the disease — the stubborn mucus, the nagging cough, and the constant threat of a flare-up. But by causing ...

An abstract using U.S. Bronchiectasis and NTM Research Registry data comparing bronchiectasis in people with and without ...

Bronchiectasis is a heterogeneous condition and may be encountered as a stand-alone pulmonary disease by primary care clinicians and specialists in pulmonary medicine. Bronchiectasis sometimes ...

This article explains the role and future prospects of dipeptidyl peptidase 1 (DPP1) inhibitors as treatments for ...

BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...